RMC-6291

RMC-6291 is an orally active and covalent inhibitor of KRASG12C(ON). RMC-6291 forms a tri-complex within tumor cells between KRASG12C(ON) and cyclophilin A (CypA).
Supplier Selleck Chemicals
Product # E1606
Sku # E1606-1mg
Pricing 1mg, $397.00
Feedback